TC
ABEO icon

TwinBeech Capital’s Abeona Therapeutics ABEO Stock Holding History

TwinBeech Capital’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,425
Closed -$58.1K – 682
2024
Q4 		$58.1K Buy
+10,425
New +$64.1K ﹤0.01% 576

Other funds holding ABEO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TwinBeech Capital's ABEO Position: Q1 2025 in Review

TwinBeech Capital sold out of Abeona Therapeutics (ABEO) in Q1 2025, closing a stake of 10,425 shares — an estimated $58.1K sold.

TwinBeech Capital first reported a position in ABEO in Q4 2024 and held it in 1 quarter. The position peaked at $58.1K in Q4 2024. 71 funds tracked by Wall St. Rank hold ABEO as of Q1 2025.

  • TwinBeech Capital reported no remaining Abeona Therapeutics position as of Q1 2025 after selling out during the quarter.
  • TwinBeech Capital sold 10,425 Abeona Therapeutics shares in Q1 2025, an estimated $58.1K.
  • TwinBeech Capital first reported a position in Abeona Therapeutics in Q4 2024 and held it in 1 quarter.
  • TwinBeech Capital's Abeona Therapeutics position peaked at $58.1K in Q4 2024.
  • 71 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2025.

Based on TwinBeech Capital's 13F filing for Q1 2025, filed 15 May 2025.